Biosynex Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 200
Employees
  • Stock Symbol
  • ALBIO
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $23.06
  • (As of Wednesday Closing)

Biosynex General Information

Description

Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
PAR
Primary Office
  • 22 Boulevard Sébastien Brant
  • Graffenstaden
  • 67400 Illkirch
  • France
+33 03 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosynex Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.06 $22.93 $13.51 - $36.41 $221M 9.6M 63.9K $4.01

Biosynex Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 188,267 188,267 30,211 31,754
Revenue 175,427 175,427 39,374 36,832
EBITDA 60,315 60,315 2,942 457
Net Income 35,759 35,759 1,229 641
Total Assets 136,090 136,090 53,034 45,141
Total Debt 19,365 19,365 11,167 5,928
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biosynex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosynex‘s full profile, request access.

Request a free trial

Biosynex Executive Team (4)

Name Title Board Seat Contact Info
Larry Abensur Co-founder & Chief Executive Officer
Thierry Paper Deputy CEO & Co-Founder
Thomas Lamy Ph.D Co-Founder & Deputy Managing Director
Elie Fraenckel Directeur Financier and RH
To view Biosynex’s complete executive team members history, request access »

Biosynex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosynex Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 30-Apr-2021 000000000000000000 Diagnostic Equipment
000000000 21-Jul-2020 00000 00000 00 000.00 Diagnostic Equipment 00000 0000000
00000000 00000 (00 04-Dec-2019 000000000 00000000 Medical Supplies
0000 03-Jul-2017 000000000000000000 Biotechnology 00000 0000000
Fumouze Diagnostics 23-May-2016 Merger/Acquisition Diagnostic Equipment 00000 0000000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Biosynex Subsidiaries (2)

Company Name Industry Location Founded
Avalun Diagnostic Equipment Grenoble, France 2013
0000000 Holding Companies Echbolsheim, France 0000
To view Biosynex’s complete subsidiaries history, request access »